Last reviewed · How we verify

NCT05837741

Leucine-enriched Formulas in Patients With Tumor-induced Sarcopenia

Completed NA Last updated 9 May 2023
What this trial tests

NA trial testing Standard hypercaloric hyperproteic oral nutritional supplement in Sarcopenia in 48 participants. Completed in 1 November 2021.

Timeline
1 March 2021
Primary endpoint
1 August 2021
1 November 2021

Quick facts

Lead sponsorMaimónides Biomedical Research Institute of Córdoba
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment48
Start date1 March 2021
Primary completion1 August 2021
Estimated completion1 November 2021
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Maimónides Biomedical Research Institute of Córdoba

Who can join

Adults 18 to 90, any sex, with Sarcopenia or Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Currently there is a lack of evidence for recommending specific oral supplements (OS) for nutritional support in patients with cancer, including leucine-enriched supplements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other Maimónides Biomedical Research Institute of Córdoba trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05837741.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing